Clinical Trial Update: Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and reactogenicity of the Rotarix rotavirus vaccine in Chinese adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 1 | Status: COMPLETED